EICKELMANN PETER,MARK MICHAEL,SEMAN LEO JOHN,THOMAS LEO,BROEDL ULI,GREMPLER ROLF
申请号：
TN2011000415
公开号：
TN2011000415A1
申请日:
2011.08.12
申请国别(地区):
TN
年份:
2013
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
